Immunomedics, Inc. (IMMU) Director Sells 8390 Shares of Stock

Share

Spark Invest Ltd Company accumulated 0.04% or 81,900 shares. (NASDAQ:IMMU) were released by: Fool.com and their article: "Why Immunomedics, Inc". (NASDAQ:IMMU). Advent Cap Management De has 55,000 shares for 0.01% of their portfolio. Massmutual Tru Fsb Adv owns 200 shares. Institutional ownership can eventually exceed 100 percent of float, which means that, in addition to all the available shares, institutions have also bought up all the borrowed shares from short sellers who are betting that the stock will decline. For the current year the company's revenue estimates are $14.97 Million compared to low analyst estimates of $2.6 Million and high estimates of $39 Million according to the prediction of 3 analysts. (NASDAQ:IMMU) for 775 shares. Immunomedics, Inc.'s now has a PEG ratio of - where as its P/E ratio is 0.00. Institutional investors own 76.32% of the company's stock. Pura Vida Investments Llc sold 288,200 shares as Immunomedics Inc (IMMU)'s stock rose 37.64%.

More notable recent Immunomedics, Inc. (IMMU) in trading session dated November 20, 2017. (NASDAQ:IMMU). 5,000 are held by Tci Wealth Advsr.

Nathan Fischel increased its stake in Immunomedics Inc (IMMU) by 152.48% based on its latest 2017Q2 regulatory filing with the SEC. Further, Orbimed Advisors Llc reported stake worth 0.06% of its portfolio. Over the last week of the month, it was 9.21%, 0.51% over the last quarter, and 44.11% for the past six months. This will give analytical advantage to a shorter-term trader since it pursues the price more intimately, and consequently produces less "lag" as comparison to the longer-term moving average.

The Relative Volume of the company is 2.89 and Average Volume (3 months) is 2.97 million. It has outperformed by 59.56% the S&P500. A reading above 70 indicates that a stock is overvalued, and a reading below 30 implies that it is undervalued.

The consensus analysts recommendation at this point stands at 1.30 on Immunomedics, Inc. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 1.30, which implies that analysts are generally bullish in their outlook for IMMU over the next year. (NASDAQ:IMMU) has "Buy" rating given on Friday, May 6 by Jefferies. (NASDAQ:IMMU) earned "Hold" rating by Jefferies on Wednesday, July 29. The company reported the earnings of $-0.97/Share in the last quarter where the estimated EPS by analysts was $-0.11/share. (NASDAQ:IMMU) for 325,000 shares. The firm engages in developing antibody-drug conjugate products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. The company was maintained on Wednesday, August 16 by Cowen & Co. Jefferies has "Hold" rating and $1.50 target. Jefferies maintained the stock with "Buy" rating in Tuesday, September 19 report. Jefferies has "Hold" rating and $1.50 target. The firm has "Buy" rating given on Monday, July 24 by Cowen & Co. (NASDAQ:IMMU) on Wednesday, December 6 with "Buy" rating. Wells Fargo downgraded Immunomedics, Inc.

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody products for the targeted treatment of cancer, autoimmune disorders, and other diseases. "Is Soaring Today" on December 06, 2017, also Globenewswire.com with their article: "Immunomedics Announces First Quarter Fiscal 2018 Results and Provides ..." published on November 09, 2017, Globenewswire.com published: "Immunomedics Announces Presentations and Investor Event at the 2017 San ..." on November 13, 2017. More interesting news about Immunomedics, Inc. Jumped Higher Today" published on November 10, 2017 as well as Seekingalpha.com's news article titled: "Immunomedics Emerges With New Leadership" with publication date: "November 14, 2017.

Share

Advertisement

Related Posts

Cemetery raises money for 'Wreaths Across America' campaign
Checks can be made to the "Enterprise Civitan Club" and can be mailed to: Enterprise Civitan Club, P. Any volunteers who would like to place honor wreaths are welcome to attend and help distribute them.

Courtois denies delaying Chelsea deal because of Real Madrid move
I just want to wait (over contract talks) because now there are many games and I prefer to have my head focused on that". However, Courtois admitted that his family situation makes the Spanish capital an attractive destination.

West Ham boss David Moyes lauds 'fantastic' Chelsea
In fact, only Manchester City and Manchester United have conceded fewer goals throughout 2017/18 than the champions. Chelsea travel to the London Stadium on Saturday to take on a West Ham team that's now in the relegation zone.

Traders should follow these: Patterson-UTI Energy, Inc. (NASDAQ:PTEN)
The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued. Sanctuary Wealth Advisors Llc holds 3.17% of its portfolio in National Beverage Corp. for 38,836 shares.

Homai Vyarawalla: First Indian Woman Photojournalist's Journey Through Odds
Soon after her husband's death, in 1970, she gave up photography disappointed with the change the profession had undergone. Her pseudonym comes from the year of her birth - 1913 - and the Dalda from her car's number plate DLD 13.

Brexit alla svolta, accordo Londra-Ue
La notizia è stata data dal presidente della Commissione Europea, Juncker a margine dell'incontro con la premier britannica, May. Per trattare gli accordi transitori, ha sottolineato Tusk, c'è "meno di un anno di tempo".

Nuggets' Kenneth Faried will come off the bench on Friday
In the loss at New Orleans, Gary Harris led the way with 24 points along with four rebounds and two assists. Denver took a one-point lead into the half and was able to separate from Orlando in the third quarter.

Rain & snow likely to hit India-SL 1st ODI in Dharamsala
Shikhar Dhawan has been suffering from fever and he missed a training session on Friday, December 8, according to Miday. Sri Lanka look to get off on a positive note against India in the first ODI in Dharamsala.

That Will Motivate You Today- Altria Group, Inc. (NYSE:MO)
The company was maintained on Friday, September 1 by RBC Capital Markets. (NYSE:MO) on Thursday, August 24 with "Hold" rating. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover MO having a buy-equivalent rating.

Newborn death case costs Max Hospital in Delhi its licence
The grandfather discovered that the baby was still alive while taking the "body" for cremation. The baby was admitted to a hospital in Pitampura but later died during treatment.

© 2015 ExpressNewsline. All Rights reserved.